Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and reactogenicity of Invivac influenza vaccine (2005/2006)
2005-003791-38Phase 3Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Aug 2005
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of virosomal influenza vaccine in influenza, sponsored by Solvay Pharmaceuticals. Primary endpoint: Serological parameters (HI titers) per CPMP/BWP/214/96. Started Aug 2005; status: completed.
02
Drugs
virosomal influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-003791-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003791-38.